Bacteriophage for treatment and prevention of E. coli and B. fragilis infections
US12268720B2 · kind B2 · utility
0Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2019 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Jun 2, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a bacteriophage composition comprising one or more (suitably two or more, or three) bacteriophages that target oncogenic (tumorigenic) bacteria, and use of the same for treating or preventing cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.